Related Experiment Videos
Novel mutations identified using a comprehensive CCR5-denaturing gradient gel electrophoresis assay
D C Petersen1, M J Kotze, M D Zeier
1Department of Human Genetics, University of Stellenbosch, Tygerberg Medical School, South Africa.
AIDS (London, England)
|February 24, 2001
Summary
Researchers developed a new assay to detect mutations in the CC chemokine receptor 5 (CCR5) gene. This identified novel CCR5 mutations in South Africans, potentially impacting HIV-1 susceptibility.
Area of Science:
- Genetics
- Immunology
- Virology
Background:
- CC chemokine receptor 5 (CCR5) gene mutations are often population-specific or rare in African populations.
- Understanding CCR5 genetic variations is crucial for studying HIV-1 susceptibility.
Purpose of the Study:
- Develop a comprehensive mutation detection assay for the entire CCR5 coding region.
- Identify novel CCR5 mutations in the diverse South African population for HIV-1 susceptibility insights.
Main Methods:
- Designed a mutation detection assay for the CCR5 coding region, including part of CCR2, using denaturing gradient gel electrophoresis (DGGE).
- Analyzed samples from 103 HIV-seropositive and 146 HIV-seronegative individuals of predominantly African descent.
Main Results:
- The CCR5-DGGE assay identified seven novel and six previously reported mutations.
- All novel mutations, including a common polymorphism at codon 35, were found exclusively in non-Caucasian individuals, suggesting African origins.
Conclusions:
- A comprehensive DGGE assay for CCR5 mutation detection was successfully developed.
- The identified novel CCR5 mutations may significantly affect CCR5 function, influencing HIV-1 susceptibility and AIDS progression in this population.